DIECI, MARIA VITTORIA

DIECI, MARIA VITTORIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 154 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
186O Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial 2018 Maria Vittoria DieciPierfranco ConteValentina Guarneri + ANNALS OF ONCOLOGY - ESMO 2018 Abstract Book (Ann Oncol)
18F-Fluoroestradiol Positron Emission Tomography In Breast Cancer Patients: Systematic Review Of The Literature &; Meta-Analysis 2016 DIECI, MARIA VITTORIAGUARNERI, VALENTINACONTE, PIERFRANCO + CURRENT RADIOPHARMACEUTICALS - -
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 2022 Griguolo, GaiaTosi, AnnaDieci, Maria VittoriaVentura, AnnaveraBottosso, MicheleMiglietta, FedericaFassan, MatteoConte, PierFrancoRosato, AntonioGuarneri, Valentina + NEURO-ONCOLOGY - -
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 2020 Guarneri, ValentinaGriguolo, GaiaDieci, Maria VUrso, LoredanaMiglietta, FedericaConte, Pierfranco + THE LANCET ONCOLOGY - -
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + CLINICAL CANCER RESEARCH - -
An overview of immune checkpoint inhibitors in breast cancer 2020 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + EXPLORATION OF TARGETED ANTI-TUMOR THERAPY - -
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 2019 Dieci M. V.TSVETKOVA, VASSILENAGriguolo G.Miglietta F.MANTIERO, MARACumerlato E.Giorgi C. A.Giarratano T.FAGGIONI, GIULIA MARTINAVernaci G.Menichetti A.MIORANZA, ELEONORAFREZZINI, SIMONAOrvieto E.Guarneri V. + FRONTIERS IN ONCOLOGY - -
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer. 2010 GUARNERI, VALENTINADIECI, MARIA VITTORIACONTE, PIERFRANCO + CANCER TREATMENT REVIEWS - -
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials 2020 Dieci M. V.Yang W.Yuan Y. + NPJ BREAST CANCER - -
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors 2017 DIECI, MARIA VITTORIA + ADVANCES IN ANATOMIC PATHOLOGY - -
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research 2017 DIECI, MARIA VITTORIA + ADVANCES IN ANATOMIC PATHOLOGY - -
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer 2019 Dieci, M VConte, PMiglietta, FGuarneri, V + ANNALS OF ONCOLOGY - -
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome 2017 GRIGUOLO, GAIADIECI, MARIA VITTORIAMIORANZA, ELEONORATASCA, GIULIAMILITE, NICOLAMiglietta, FedericaCONTE, PIERFRANCOGUARNERI, VALENTINA + JOURNAL OF NEURO-ONCOLOGY - -
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors 2020 Dieci M. V.Miglietta F.Griguolo G.Guarneri V. CANCER TREATMENT REVIEWS - -
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis 2019 Vernaci G.Dieci M. V.MANFRIN, SILVIAMantiero M.Menichetti A.Griguolo G.Miglietta F.Di Liso E.Conte P.Guarneri V. + THE BREAST - -
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspective 2020 Dieci M. V. + ESMO OPEN - -
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 2019 S. FrezziniT. GiarratanoG. GriguoloL. PiccinE. MioranzaA. MenichettiF. MigliettaE. GenovesiE. CumerlatoM. BottossoG. VernaciM. V. Dieci + TUMORI - -
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 2011 DIECI, MARIA VITTORIACONTE, PIERFRANCOGuarneri V. + CANCER RESEARCH - -
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy 2023 Edoardo Vincenzo SavarinoIlaria PatuzziFabiana ZingoneFederica MigliettaGaia GriguoloMatteo FassanValentina GuarneriMaria Vittoria Dieci + THE ONCOLOGIST - -